Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04002700 · ClinicalTrials.gov registry record

A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group

A clinical trial of Stroke, sponsored by Janssen Research & Development.

Completed
Registry status
1,234,412
Enrollment target
1
Study location

NCT04002700 is a study of Stroke that has completed, run by Janssen Research & Development. The registered enrollment target is 1,234,412 participants, above the 9,297-participant average among 454 other Stroke trials with a reported enrollment target (13178% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04002700, a study of Stroke, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
1,234,412 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to extend the recent Food and Drug Administration (FDA) Sentinel tabulations regarding stroke risk among new users of typical and atypical antipsychotics to participants who were aged 18-64 years and did not have dementia to participants aged 65 years and older regardless of dementia status.

Conditions Studied

Stroke

Interventions

  • DRUG Haloperidol
  • DRUG Typical Antipsychotics
  • DRUG Atypical Antipsychotics

Study Locations (1)

New Jersey

  • Janssen Investigative Site - Titusville

Trial Details

FieldValue
Enrollment Target 1,234,412 participants
Start Date 2019-05-06
Est. Completion 2019-05-31

Sponsor

Janssen Research & Development

593 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04002700

The ClinicalTrials.gov registry entry for NCT04002700 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,234,412 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 9,297-participant average among 454 other Stroke trials with a reported enrollment target (13178% higher). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Haloperidol is the first listed.

NCT04002700 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04002700 about?

NCT04002700 is a clinical study titled "A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group". The purpose of this study is to extend the recent Food and Drug Administration (FDA) Sentinel tabulations regarding stroke risk among new users of typical and atypical antipsychotics to participants who were aged 18-64 years and did not have dementia to participants aged 65 years and older regardles...

What is the current status of trial NCT04002700?

This trial is currently completed. The enrollment target is 1,234,412 participants. The study started on 2019-05-06. Estimated completion is 2019-05-31.

What conditions does trial NCT04002700 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04002700?

The interventions under investigation include: Haloperidol (DRUG), Typical Antipsychotics (DRUG), Atypical Antipsychotics (DRUG).

Who is sponsoring clinical trial NCT04002700?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04002700 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.